Charts Of The Day: If you want to play with the no sales biotechs – be prepared for anything!
Charts courtesy of Stockcharts.com No positions
Charts courtesy of Stockcharts.com No positions
The jury’s still out on how history will treat the Federal Reserve’s unprecedented stimulus program. After the central bank pushed its main policy rate to zero
OPEC expected to leave crude oil output unchanged, showing how cartel’s power to sway prices has ebbed Source: http://www.wsj.com/articles/opecs-pricing-leverage-is-weakening-1433117819
Drugs in short supply include cancer treatments and antibiotics; manufacturing snafus Read More: http://www.wsj.com/articles/u-s-drug-shortages-frustrate-doctors-patients-1433125793
Are You ‘Over-Exposed’ Online? Lessons From IRS Hack – Fox Business A Game Changer in Cancer Treatment – Fox Business FOX Business Network’s New Line-Up
We are less than thrilled at what we are seeing here. End of quarter today not so good. 50% of the market is already bearish…which
TEVA buys ASPX for $3.2 billion in cash. ASPX has no sales. That’s not to say that they wont have sales going forward. Just remember
Source: http://davidstockmanscontracorner.com/q1-earnings-alert-worst-sales-and-profits-decline-since-2009/